Decitas 50 mg Injection
$48.16
$34.39
Decitas 50 mg injection is a targeted anti-cancer therapy designed to manage myelodysplastic syndromes (MDS), a collection of disorders characterized by the ineffective production of healthy blood cells in the bone marrow. This medication works by promoting the maturation of blood cell precursors, thereby reducing the proliferation of immature cells known as blasts. Patients receiving Decitas should be monitored for potential side effects, which may include low blood cell counts, and should be aware of the risk of infections due to compromised immunity. It is crucial to inform your healthcare provider about any existing medical conditions or medications you are taking before starting treatment with Decitas. As an effective option for MDS, this injection aims to improve blood cell production and enhance overall health. Always follow your healthcare professional’s guidance regarding dosage and administration to ensure the best outcomes. With careful monitoring and adherence to treatment protocols, Decitas can play a significant role in the management of myelodysplastic syndromes, contributing to better patient quality of life.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Decitas 50 mg injection is primarily used in the treatment of myelodysplastic syndrome (MDS), a disorder where the bone marrow produces abnormal blood cells. These cells can lead to a reduction in healthy blood cells, which may result in symptoms such as fatigue and weakness. By targeting the underlying issues in MDS, Decitas helps improve blood cell production and overall patient well-being. This medication is essential for patients experiencing complications from this condition.
• In addition to MDS, Decitas 50 mg injection is effective in treating acute myeloid leukemia (AML), a form of blood cancer that impacts the production of white blood cells. Patients with AML may experience a range of symptoms, including severe fatigue, frequent infections, and easy bruising. The administration of Decitas works to combat the cancerous cells, supporting the restoration of healthy blood cell levels. This treatment option is crucial for individuals facing the challenges of AML.
• Decitas 50 mg injection can also be utilized in patients who have undergone previous treatments for MDS or AML and require additional therapy. This medication plays a key role in managing the disease, particularly when initial treatments are insufficient. By providing a targeted approach to therapy, Decitas can enhance the quality of life for patients who need ongoing support. Healthcare providers often consider Decitas as part of a comprehensive treatment plan for these conditions.
• The use of Decitas 50 mg injection is significant in patients who are not responding adequately to standard therapies for MDS and AML. Its unique mechanism of action allows it to address specific cellular abnormalities in the bone marrow. As a result, Decitas can improve hematological parameters and reduce disease-related symptoms. This makes it a valuable option for clinicians aiming to optimize treatment outcomes in challenging cases.
Benefits
Myelodysplastic syndrome: Decitas 50 mg Injection is used to treat myelodysplastic syndrome, a group of conditions in which the bone marrow produces blood cells that are abnormal in structure and function and does not produce enough healthy blood cells. Decitas Injection for AML kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Acute myeloid leukemia (AML): Decitabine Cancer Injection is used to treat acute myeloid leukemia, a type of blood cancer that affects the white blood cells, specifically, the myeloid cells, which are responsible for producing red blood cells, platelets, and other white blood cells. In AML, the myeloid cells become abnormal and do not function properly, leading to a decrease in healthy blood cells and an increase in abnormal cells. Decitabine 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells.
Side Effects
Most adverse effects do not require medical attention and will go away when your body gets used to the medicine. Inform your doctor if any of these symptoms get severe or that bother you for a longer period.
Most Common Side Effects
• Insomnia
• Nausea
• Constipation
• Diarrhoea
• Vomiting
• Stomach pain
• Painful sores in mouth or tongue or lips
• Indigestion
• Heartburn
• Rashes
• Itching
• Hair loss
• Skin discolouration
• Chest discomfort
• Muscle pain
• Joint pain
• Swelling over extremities
• Pain or swelling or redness over the injection site
• Weakness
• Confusion
• Headache
• Dizziness
• Extreme weakness
Common Side Effects
• Bruising
• Unusual bleeding
• Facial swelling
• Respiratory distress, breathing difficulty, rapid breathing, tachypnoea
• Sore throat
• High
• grade fever with chills
• Other signs of infection
How To Use
Decitas 50 mg Injection is available in powder form, which must be diluted and administered into the vein (IV) slowly as directed by your doctor. Decitabine 50 mg Injection is administered by a doctor or nurse at a hospital or clinical setting. The dosage, frequency, and interval (duration of infusion) depend upon your medical condition, body size, lab test results, and response towards the treatment given. Don't administer this drug by yourself; it must be administered under medical supervision by healthcare professionals only. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to. You should avoid drinking alcohol, as it may increase your risk of liver damage. Do not self-administer this Decitas 50 mg.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Decitas 50 mg. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Decitas 50 mg Injection is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Decitas 50 mg Injection is recommended. The use of Decitas 50 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Decitas 50 mg. Decitas 50 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Decitas 50 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Decitas 50 mg Injection is recommended for use in patients with mild to moderate liver disease. No dose adjustment is needed in such types of patients. In case patients suffer from severe liver disease, the use of this medicine in such types of people is not recommended, It may worsen the patient's condition.
• Pregnancy: Use of Decitas 50 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Decitas 50 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Decitas 50 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Decitas 50 mg.